OncoSec Medical to begin three phase II trials of ElectroImmunotherapy technology in cancer May 31, 2011
Pharmascience to expand research and development activities with acquisition of Aegera Therapeutics May 31, 2011
MediGene and Johns Hopkins to collaborate on development of vaccine candidates from AAVLP program May 31, 2011
Interim phase II/III analysis points to benefits of Urocidin in non-muscle-invasive bladder cancer May 31, 2011
RSS